Susquehanna International Group’s Neos Therapeutics, Inc NEOS Stock Holding History

Susquehanna International Group’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,300	Closed	-$8K	–	11349
2020 Q1	$8K	Buy	11,300 +500	+5%	+$687	﹤0.01%	10065
2019 Q4	$16K	Buy	+10,800	New	+$16.2K	﹤0.01%	9517
2019 Q2	–	Sell	-30,500	Closed	-$80K	–	11120
2019 Q1	$80K	Sell	30,500 -5,700	-16%	-$13.4K	﹤0.01%	8332
2018 Q4	$60K	Sell	36,200 -13,100	-27%	-$36.8K	﹤0.01%	8419
2018 Q3	$239K	Buy	49,300 +9,900	+25%	+$56.1K	﹤0.01%	7913
2018 Q2	$246K	Sell	39,400 -2,600	-6%	-$19.4K	﹤0.01%	8227
2018 Q1	$349K	Sell	42,000 -36,700	-47%	-$350K	﹤0.01%	7368
2017 Q4	$803K	Buy	78,700 +29,900	+61%	+$287K	﹤0.01%	5687
2017 Q3	$447K	Buy	48,800 +24,100	+98%	+$183K	﹤0.01%	6706
2017 Q2	$180K	Buy	+24,700	New	+$186K	﹤0.01%	8368

Susquehanna International Group's NEOS Position: Q1 2021 in Review

Susquehanna International Group sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 245,105 shares — an estimated $153K sold.

Susquehanna International Group first reported a position in NEOS in Q4 2016 and held it in 9 quarters. The position peaked at $2.33M in Q3 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

Susquehanna International Group reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
Susquehanna International Group sold 245,105 Neos Therapeutics, Inc shares in Q1 2021, an estimated $153K.
Susquehanna International Group first reported a position in Neos Therapeutics, Inc in Q4 2016 and held it in 9 quarters.
Susquehanna International Group's Neos Therapeutics, Inc position peaked at $2.33M in Q3 2017.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.